14 November is World Diabetes Day
Noncommunicable Diseases, Rehabilitation and Disability
We are responsible for leading, coordinating and monitoring global action to cover additional people with health services, medicines, vaccines, diagnostic and health technologies for the prevention, screening, early diagnosis and appropriate treatment of cardiovascular diseases, cancers, chronic respiratory diseases and diabetes. We aim to advance health equity for persons with disabilities, we have a focus on sensory impairments and bring together the work on rehabilitation from across the departments and from the 3 levels of the organization.
Diabetes programme
The Diabetes programme, named The WHO Global Diabetes Compact, has the vision of reducing the risk of diabetes, and ensuring that all people who are diagnosed with diabetes have access to equitable, comprehensive, affordable and quality treatment and care.
Coverage targets
There are 5 global coverage targets for diabetes to be achieved by 2030:
- 80% of people with diabetes are diagnosed;
- 80% of people with diagnosed diabetes have good control of glycaemia;
- 80% of people with diagnosed diabetes have good control of blood pressure;
- 60% of people with diabetes of 40 years or older receive statins; and
- 100% of people with type 1 diabetes have access to affordable insulin and blood glucose self-monitoring.
Workstreams
The Global Diabetes Compact works through 6 workstreams to advance the diabetes agenda and accelerate progress towards the global coverage targets:
- access to essential diabetes medicines and associated health technologies;
- technical products;
- prevention, health promotion and health literacy;
- country support;
- research and innovation; and
- governance, strategy and partnerships.
Campaigns
Our work
Country profiles
Country profiles
Country profiles present selected data, statistics and information to provide national health profiles at given points in time.
Related publications
All →This report presents a global mapping of glucagon-like peptide-1 receptor agonist manufacturers, with a particular focus on semaglutide. The mapping describes...
9 September 2026
Global mapping of insulin manufacturers
This report presents a global mapping of insulin manufacturers. The report outlines proposed actions that may inform efforts to improve transparency in...
Prevention and Control of Diabetes Mellitus: Lessons for Service Delivery from Countries in the WHO South-East Asia Region presents practical experiences...
14 November 2025
WHO recommendations on care for women with diabetes during pregnancy
WHO maternal and perinatal health guidelines are relevant to those providing care and support during pregnancy, labour, childbirth and postnatal periods,...
12 November 2025
Global tuberculosis report 2025
The WHO Global tuberculosis report 2025 provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, ...
23 September 2025
Availability, price and affordability of health technologies for the management of diabetes
The WHO list of priority medical devices for management of cardiovascular diseases and diabetes, https://iris.who.int/handle/10665/341967, describes those...
1 September 2025
WHO guideline on HIV service delivery
This WHO guideline recommends integrating services for hypertension, diabetes, and mental health (including depression, anxiety, and substance use) into...
18 November 2024
The Global Diabetes Compact: progress in supporting its workstreams: technical report
In 2021, WHO launched the Global Diabetes Compact (GDC), an initiative to reduce the risk of diabetes and ensure that all people who are diagnosed with...
14 November 2024
Guidance on global monitoring for diabetes prevention and control: Framework, indicators and application
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing...
Other technical resources
